Skip to main content
. 2013 Feb 9;8:535–544. doi: 10.2147/IJN.S39383

Figure 2.

Figure 2

Dapsone release profile from nanoemulsion A (A) and nanoemulsions B, C, and D (B) with the drug incorporated in the oil phase (OP) and in the finished formulation (FF).

Abbreviation: DAP, dapsone; NE, nanoemulsion; IPM, isopropyl myristate; NMP, n-methyl-pyrrolidone; OP, oil phase; FF, finished formulation.